Shares in Smith & Nephew, the hip and knee replacement maker, jumped almost 9 per cent today on rumours that it could the the subject of an £8billion bid from U.S. rival Biomet. Hull-based Smith & Nephew (S&N) saw its stock rise by 51 points to 648.25 - some 8.6 per cent - at one stage this morning before settling 28.75 points, or 40.87 per cent, up at 625.25 by 11.15am. S&N refused to comment on speculation that American medical device manufacturer Biomet was plotting a 900p a share approach.
